Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Keratinocyte Growth Factor

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06283316Recruiting

Systemic Treatments for Alopecia Areata Registry

NCT04554732Early Phase 1Completed

Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

Showing all 2 trials

Research Network

Common Treatments

  • Keratinocyte Growth Factor1

Active Sponsors

  • Erasmus Medical Center1
  • University of Arizona1

Top Investigators

Related Conditions

  • Hair Loss2
  • Alopecia2
  • Chemotherapyinduced Change1
  • Hair Diseases1
  • Alopecia Universalis1

Activity Timeline